Codexis (CDXS) Change in Accured Expenses (2010 - 2020)
Codexis (CDXS) recorded quarterly Change in Accured Expenses of $3.9 million in Q4 2020, up 24.13% quarter-over-quarter from $3.1 million in Q1 2020, and up 39.04% on a YoY basis from $2.8 million in Q1 2020.
Codexis (CDXS) Change in Accured Expenses (2010 - 2020) Analysis & Trends
Codexis' Change in Accured Expenses history runs 11 years deep, the most recent figure standing at $3.9 million for Q4 2020.
- In Q4 2020, Change in Accured Expenses rose 39.04% year-over-year to $3.9 million; the TTM figure through Dec 2020 stood at $9.9 million (up 349.43% YoY), while the FY2022 annual figure was $6.0 million, down 9.0% from the prior year.
- Change in Accured Expenses was $3.9 million for Q4 2020 at Codexis, up from $3.1 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $3.9 million in Q4 2020 to a low of -$2.4 million in Q2 2017.
- Historically, Change in Accured Expenses has averaged $529833.3 across 5 years, with a median of $626500.0 in 2016.
- Biggest YoY gain for Change in Accured Expenses was 571.72% in 2017; the steepest drop was 183.0% in 2017.
- A 5-year view of Change in Accured Expenses shows it stood at -$653000.0 in 2016, then tumbled by 183.0% to -$1.8 million in 2017, then soared by 55.09% to -$830000.0 in 2018, then jumped by 435.18% to $2.8 million in 2019, then surged by 39.04% to $3.9 million in 2020.
- The last three Change in Accured Expenses figures came in at $3.9 million (Q4 2020), $3.1 million (Q1 2020), and $2.8 million (Q4 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 931,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 3.87 Mn |
| Dec 31, 2020 | 3.87 Mn |
| Mar 31, 2020 | 3.12 Mn |
| Mar 31, 2020 | 3.12 Mn |
| Dec 31, 2019 | 2.78 Mn |
| Dec 31, 2019 | 2.78 Mn |
| Sep 30, 2019 | 144,000.00 |
| Sep 30, 2019 | 144,000.00 |
| Jun 30, 2019 | -1.92 Mn |
| Jun 30, 2019 | -1.92 Mn |
| Mar 31, 2019 | 1.20 Mn |
| Mar 31, 2019 | 1.20 Mn |
| Dec 31, 2018 | -830,000.00 |
| Dec 31, 2018 | -830,000.00 |
| Sep 30, 2018 | 2.27 Mn |
| Sep 30, 2018 | 2.27 Mn |
| Jun 30, 2018 | -1.64 Mn |
| Jun 30, 2018 | -1.64 Mn |
| Mar 31, 2018 | 705,000.00 |
| Mar 31, 2018 | 705,000.00 |